← All Sponsors
SPONSOR

University of Miami

Total Trials
19
Recruiting
19
Phases
Phase 2, Phase 4

University of Miami is a clinical research sponsor with 19 registered studies on ClinicalTrials.gov, of which 19 are actively recruiting participants. Research covers conditions including Hodgkin Lymphoma, Advanced Hodgkin Lymphoma, Gastrointestinal Cancer, HIV Associated Polyneuropathy.

The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Miami

How many clinical trials has University of Miami sponsored?
ClinicalMetric currently tracks 19 clinical trials sponsored by University of Miami, of which 19 are actively recruiting participants. These trials cover conditions including Hodgkin Lymphoma, Advanced Hodgkin Lymphoma, Gastrointestinal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Miami research focus on?
University of Miami clinical trials span Hodgkin Lymphoma, Advanced Hodgkin Lymphoma, Gastrointestinal Cancer, HIV Associated Polyneuropathy, Multiple Myeloma, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Miami clinical trial?
To participate in a University of Miami trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Miami trials with current recruitment status updated daily.

Clinical Trials by University of Miami

NCT07002216 Phase 2
Recruiting

BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma

Hodgkin Lymphoma
NCT06569693
Recruiting

Dyadic Sleep Study

Gastrointestinal Cancer
NCT07822932
Recruiting

Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated Peripheral Neuropathy

HIV Associated Polyneuropathy
NCT06997081 Phase 2
Recruiting

ERd Combination Treatment in Newly Diagnosed Multiple Myeloma (ADVANCE 2.0)

Multiple Myeloma
NCT07217678 Phase 4
Recruiting

Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

Glaucoma
NCT05839210
Recruiting

Lifestyle Intervention of Food and Exercise for Lymphoma Survivors

Non Hodgkin Lymphoma
NCT06663722 Phase 2
Recruiting

Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

Chronic Graft Versus Host Disease
NCT07437469
Recruiting

Binaural Beats for Postoperative Pain and Anxiety Reduction

TKA
NCT03135327
Recruiting

Clinical Applications of Advanced Ophthalmic Imaging

Multiple Sclerosis
NCT00317616
Recruiting

The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study

Amyotrophic Lateral Sclerosis
NCT06089161
Recruiting

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

Sleep Apnea
NCT06487507
Recruiting

Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)

Prostate Cancer
NCT06807866 Phase 4
Recruiting

Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT

THA
NCT03684109
Recruiting

Non-invasive Glioma Characterization Through Molecular Imaging

Glioma
NCT06902285 Phase 4
Recruiting

Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty

Sleep
NCT06261346
Recruiting

Plasma Rich in Growth Factors in Corneal Endothelial Transplantation

Fuchs' Endothelial Dystrophy
NCT05454267
Recruiting

Early Detection of Vaping-related Vascular Diseases

Vaping
NCT06919939 Phase 2
Recruiting

Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma

Large B-cell Lymphoma
NCT07340671
Recruiting

Facial Papules in Frontal Fibrosing Alopecia (FFA)

Frontal Fibrosing Alopecia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology